Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01203332 |
Recruitment Status :
Completed
First Posted : September 16, 2010
Last Update Posted : February 28, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
HIV | Behavioral: Effectiveness of different strategies in HIV testing and linkage to care |
Study Type : | Observational |
Actual Enrollment : | 1917 participants |
Observational Model: | Ecologic or Community |
Time Perspective: | Cross-Sectional |
Official Title: | Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults |
Study Start Date : | July 2010 |
Actual Primary Completion Date : | January 2013 |
Actual Study Completion Date : | January 2013 |
Group/Cohort | Intervention/treatment |
---|---|
Alternative Venue Testing (AVT)
Participants recruited for testing through the AVT recruitment method.
|
Behavioral: Effectiveness of different strategies in HIV testing and linkage to care
HIV testing Linkage to Care |
SSNIT - Index Recruiter
Participants recruited for HIV testing and to bring members of their social and sexual network to the study.
|
Behavioral: Effectiveness of different strategies in HIV testing and linkage to care
HIV testing Linkage to Care |
SSNIT - Network Member
Participants recruited by someone in their social or sexual network to participate in the study, including HIV testing.
|
Behavioral: Effectiveness of different strategies in HIV testing and linkage to care
HIV testing Linkage to Care |
- Effectiveness of AVT strategy with SSNIT [ Time Frame: 2 years ]To compare the relative effectiveness of AVT with SSNIT, which is a coupon-based index recruiter driven network recruitment strategy for identifying previously undiagnosed HIV infection among Hispanic/Latino adolescents and young adults aged 13-24 years.
- Facilitators & barriers to HIV testing [ Time Frame: 2 years ]To examine factors that facilitate and/or hinder Hispanic/Latino adolescents and young adults in getting an HIV test (e.g., perceived risk for HIV, acculturation, homophobia, stigma associated with IDU).
- Sub-group differences [ Time Frame: 2 years ]To explore the extent to which sub-group differences (e.g., origin of birth, age, level of acculturation) exist by prevalence of HIV-related risk behaviors, HIV testing, and mode of HIV transmission.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 13 Years to 24 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
1. Inclusion Criteria
1a. Alternative Venue-Based Testing (AVT) Participants
- Self-identifies as being of Hispanic or Latino ethnicity;
- Provides verbal confirmation that his/her age is between 13 years, 0 days to 24 years, 364 days at the time of enrollment;
- Self-reports a negative or unknown HIV status;
- Is male and self-reports any unprotected anal sex with a male sexual partner in the past three months; OR Is female and self-reports any unprotected anal or vaginal sex with two or more male sexual partners in the past three months; OR Is female and self-reports any unprotected anal or vaginal sex with a male sexual partner who was incarcerated in the past 12 months; OR Is male or female and self-reports any history of injection drug use; OR Is male or female and self-reports any unprotected anal or vaginal sex with an individual who is known to be HIV positive; OR Is male or female and self-reports any unprotected anal or vaginal sex with an injection drug user in the past 12 months;
- Willing to complete an HIV risk assessment;
- Willing to undergo HIV screening; and
-
Able to understand and willing to provide signed informed consent/assent in English or Spanish.
1b. Social and Sexual Index Recruiter Participants
- Self-identifies as being of Hispanic or Latino ethnicity;
- Provides verbal confirmation that his/her age is between 13 years, 0 days to 24 years, 364 days at the time of enrollment;
- Is male or female and self-reports being diagnosed with HIV in the past 12 months; OR Is female and self-reports any unprotected anal or vaginal sex with a male sexual partner who was incarcerated in the past 12 months; OR Is male or female and self-reports any history of injection drug use; OR Is male or female and self-reports any unprotected anal or vaginal sex with an individual who is known to be HIV positive; OR Is male or female and self-reports any unprotected anal or vaginal sex with an injection drug user in the past 12 months;
- Willing to complete a HIV risk assessment;
- Willing to undergo HIV screening (or an HIV confirmatory test if previously diagnosed);
- Willing to recruit one or more Latino/Latina family members, friends, or sexual partners who are between the ages of 13-24 years and who meet the criteria for a Social and Sexual Network Member for participation in the study; and
-
Able to understand and willing to provide signed informed consent/assent in English or Spanish.
1c. Social and Sexual Network Members
- Self-identifies as being of Hispanic or Latino ethnicity;
- Provides verbal confirmation that his/her age is between 13 years, 0 days to 24 years, 364 days at the time of enrollment;
- Self-reports any anal or vaginal sexual activity in the past 3 months and any unprotected anal or vaginal sex in the last 12 months; OR Self-reports any history of injection drug use;
- Willing to complete a HIV risk assessment;
- Willing to undergo HIV screening; and
-
Able to understand and willing to provide signed informed consent/assent in English or Spanish.
1d. Additional Inclusion Criteria for Social and Sexual Network Member Recruiters
- Is male or female and self-reports being diagnosed with HIV in the past 12 months; OR Is female and self-reports any unprotected anal or vaginal sex with a male sexual partner who was incarcerated in the past 12 months; OR Is male or female and self-reports any history of injection drug use; OR Is male or female and self-reports any unprotected anal or vaginal sex with an individual who is known to be HIV positive; OR Is male or female and self-reports any unprotected anal or vaginal sex with an IDU in the past 12 months; and
-
Willing to recruit one or more Latino/Latina family members, friends, or sexual partners who are between the ages of 13-24 years and who meet the criteria for Social and Sexual Network Members for participation in the study.
2. Exclusion Criteria
2a. All Participants
- Previous participation in ATN 096 as an AVT or a SSNIT study participant;
- Current or prior participation in ATN 084;
- Anything that would impair the participant's ability to provide informed consent/assent and/or interfere with the protocol's objectives; i.e., readily apparent psychiatric symptoms (hallucinations, thought disorder), visibly distraught (suicidal, homicidal, exhibiting violent behavior) or visibly intoxicated or under the influence of alcohol or other substances at the time of study enrollment, and
-
Acute illness that, in the opinion of study staff, would interfere with the participant's ability to adhere to the protocol requirements and/or interfere with the protocol objectives.
2b. Additional Exclusion Criteria for Alternative Venue-Based Testing Participants
- Self-reports a prior diagnosis of HIV

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01203332
United States, California | |
Childrens Hospital Los Angeles | |
Los Angeles, California, United States, 90027 | |
University of California San Francisco | |
San Francisco, California, United States, 94117 | |
United States, District of Columbia | |
Childrens National Medical Center | |
Washington, District of Columbia, United States, 20010 | |
United States, Florida | |
Childrens Diagnostic & Treatment Center | |
Fort Lauderdale, Florida, United States, 33316 | |
University of Miami School of Medicine | |
Miami, Florida, United States, 33101 | |
University of South Florida | |
Tampa, Florida, United States, 33606 | |
United States, Illinois | |
Ruth M Rothstein CORE Center/ John H Stroger Jr Hospital | |
Chicago, Illinois, United States, 60612 | |
United States, Maryland | |
University of Maryland | |
Baltimore, Maryland, United States, 21201 | |
United States, New York | |
Montefiore Medical Center | |
Bronx, New York, United States, 10467 | |
Mount Sinai Medical Center | |
NY, New York, United States, 10128 | |
United States, Pennsylvania | |
Childrens Hospital of Philadelphia | |
Philadelphia, Pennsylvania, United States, 19104 | |
United States, Tennessee | |
St. Jude Childrens Research Hospital | |
Memphis, Tennessee, United States, 38105-2794 | |
Puerto Rico | |
University of Puerto Rico | |
San Juan, Puerto Rico, 00936-5067 |
Study Chair: | Cherrie B. Boyer, Ph.D. | Adolescent Trials Network | |
Study Chair: | Jonathan M. Ellen, M.D. | Adolescent Trials Network |
Responsible Party: | University of North Carolina, Chapel Hill |
ClinicalTrials.gov Identifier: | NCT01203332 |
Other Study ID Numbers: |
ATN 096 |
First Posted: | September 16, 2010 Key Record Dates |
Last Update Posted: | February 28, 2017 |
Last Verified: | March 2016 |
HIV testing Latino Latina Men who have sex with men |
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |